[1] |
LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui.
Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
|
[2] |
WANG Haodi, DENG Zhengming, WANG Gang, JIANG Zhiwei.
Disease burden in colorectal cancer attributed to fasting hyperglycemia in china from 1990 to 2021 and projections of future trends
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 61-67.
|
[3] |
CAO Le, MA Minmin, LI Wenmin, SHUI Mingming, JIANG Cheng.
Trend of mortality and disease burden of gastric cancer in China,2004—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 68-73.
|
[4] |
CHEN Xiaodan, ZHOU Shu, LYU Yanru, XU Zhiyong, LAN Haiyan, LU Shui, GAO Shan, SHU Liuyang, LIN Siyang, HAO Yanrong, XIE Yanyan.
Study on the initial titration dose and genetic polymorphism of oxycodone hydrochloride prolonged-release tablets in the treatment of severe cancer pain
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 74-80.
|
[5] |
ZENG Lijie, WANG Liang, YANG Lei .
Clinical features and treatment efficacy analysis of central nervous system involvement in extranodal nasal-type natural killer/T-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 81-87.
|
[6] |
GUO Zhiyu, CAO Tianyu, WANG Weidong, GUO Xingxian, MA Wanqi, LU Yuanyuan, ZHAO Xiaodi, JI Gang.
Correlation between blood lipid levels and survival prognosis of gastric cancer patients under operation: A retrospective cohort study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 687-693.
|
[7] |
AN Yanxiao, JIAO Hanliang, QI Yanwei, ZHONG Zhiyong.
Effects of lncRNA PSMA3-AS1 on proliferation,migration and invasion of neuroblastoma cells by regulating the miR-186?5p/SOX4 axis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 715-721.
|
[8] |
ZHAO Wensi, KE Shaobo, CHEN Jiamei, WU Yong, ZHANG Caiyutian, CHEN Yongshun.
Efficacy and safety of Fruquintinib combined with immune checkpoint inhibitors in later-line treatment of patients with microsatellite stable metastatic colorectal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 598-605.
|
[9] |
ZHANG Tianyang, XIAO Wen, XIN Zhenjiang, XIE Junqing.
Analysis of screening results of early diagnosis and treatment program for colorectal cancer in rural areas Fengtai district,Beijing,2015—2022
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 447-453.
|
[10] |
ZHANG Siyi, HUANG Xiangyang, QIN Yunying, LIU Lijuan, HUANG Caiyun, LUO Ningbin.
Preoperative CT signs combined with clinical indicators predict the expression of cytokeratin 19 in hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 461-467.
|
[11] |
FANG Liaoxin, KANG Xiaofeng, XUE Chunyuan, PAN Lu, CHEN Jiaxin, TANG Chuanhao, SUN Liying, XU Xiaojie, DU Yimeng .
Effects of Omicron variant XBB.. spike protein on biological function of human non-small cell lung cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 271-276.
|
[12] |
LI Huadao, LIN Liqiao, LIANG Yubing, HUANG Enhao, PAN Linghui.
Effects of Herba Houttuyniae on the biological behavior of liver cancer cells and a network pharmacology analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 277-284.
|
[13] |
ZUO Juntao, LI Jiaqi, XU Yao, CAI Lina, ZHENG Hengyu, SUN Ting, YE Xianghong.
Summary of the best evidence for perioperative nutritional management in patients with colorectal cancer by the concept of enhanced recovery
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 339-345.
|
[14] |
LI Ting, LI Qian, LI Yongqiang, LIAO Xiaoli.
Analysis of prognostic factors for patients with mismatch repair?proficient advanced colorectal cancer treated by immunotherapy combined with targeted therapy and its prediction nomogram construction
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 215-222.
|
[15] |
DONG Jiaqi, FANG Tao, OU Yong, WEI Jingyi, HU Longquan, LI Yuanyuan, CHAO Xu.
Vitexicarpin inhibits the proliferation of liver cancer cells by regulating glucose metabolism reprogramming
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 615-622.
|